eli lilly and company tirzepatide reports MASH success during Q4 earnings Updated: Eli Lilly's tirzepatide breaks

95% CI, 11.9 to 9.4)

Los medicamentos como Ozempic (semaglutida) son agonistas GLP-1 aprobados por la FDA que requieren prescripcin mdica y han demostrado eficacia robusta en ensayos clnicos controlados

The physiology of weight regain after stopping GLP-1 therapy is well understood

Creatine also plays a role in brain energy metabolism, and some research suggests it may support cognitive function

Research is mixed, but a 2025 systematic review reported that microbiome interventions (e.g., probiotics) generally improved body weight, body fat percentage, and metabolic parameters (e.g., lipid levels, glucose metabolism) in people with obesity